65
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Increased fecal leukocytes may reflect resolution of IBD

&
Pages 251-252 | Received 10 Sep 2010, Accepted 18 Sep 2010, Published online: 24 Oct 2010

References

  • Persson CG, Uller L. Review: resolution of cell-mediated airways diseases. Respir Res 2010;11:75.
  • Persson CG, Uller L. Review: transepithelial exit of leukocytes – inflicting, reflecting or resolving airway inflammation? Thorax [E-Pub ahead of print: 4 August 2010] doi:10.113/thx.2009.133363.
  • Siegmund B. Targeted therapies in inflammatory bowel disease. Dig Dis 2009;27:465–9.
  • Huttenlocher A, Poznansky MC. Reverse leukocyte migration can be attractive or repulsive. Trends Cell Biol 2008;18:298–306.
  • Bromley SK, Thomas SY, Luster A. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 2005;6:895–901.
  • Sipponen T, Björkesten C-G, Färkkilä M, Nuutinen H, Savilahti E, Kolho K-L. Faecal calprotectin and lactoferrin ar reliable surrogate markers of endoxcopic response during Crohn's disease treatment. Scand J Gastroenterol 2010;45:325–31.
  • Malickova K, Kalousova M, Fucikova T, Bortlik M, Duricova D, Komarek V, Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes. Scand J Clin Lab Invest 2010;70:294–9.
  • Kolho K-L, Raivio T, Lindahl H, Savilahti E. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease. Scand J Gastroenterol 2006;41:720–5.
  • Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008;14:147–61.
  • Bellamy JEC, Nielsen NO. Immune-mediated emigration of neutrophils into the lumen of the small intestine. Infect Immunity 1074;9:615–19.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.